alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



EXHIBIT 31.2
 CERTIFICATION PURSUANT TO
EXCHANGE ACT RULE 13a-14(a)
  1.
    
    I have reviewed this Report on Form 10-Q of International Absorbents Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have:
 (a)
    
    Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in
which this report is being prepared;(b)
    
    Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report
based on such evaluation; and(c)
    
    Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter
(the registrants fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrants
internal control over financial reporting; and
 5.
    
    The registrants other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
functions):
 (a)
    
    All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely
affect the registrants ability to record, process, summarize and report financial
information; and(b)
    
    Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting.
 Date:  June 9, 2006
    

/s/   David H. ThompsonDavid H. ThompsonSecretary and Chief Financial Officer
Exhibit 32.2
 
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable,
of the Securities Exchange Act of 1934, as amended; and(2)
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 /s/ Mark T. DetillionMark T. DetillionChief Financial OfficerApril 26, 2010 The foregoing certification is being furnished solely to accompany this Report pursuant to 18
U.S.C. §1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, and is not to be incorporated by reference into any filing of the Company,
whether made before or after the date hereof, regardless of any general incorporation language in
such filing.
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.3500 Rickettsia serological reagents. ( a ) *Identification.* Rickettsia serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to rickettsia in serum. Additionally, some of these reagents consist of rickettsial antisera conjugated with a fluorescent dye (immunofluorescent reagents) used to identify rickettsia directly from clinical specimens. The identification aids in the diagnosis of diseases caused by virus-like bacteria belonging to the genus *Rickettsiae* and provides epidemiological information on these diseases. Rickettsia are generally transmitted by arthropods (e.g., ticks and mosquitoes) and produce infections in humans characterized by rash and fever (e.g., typhus fever, spotted fever, Q fever, and trench fever).
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 65 FR 2312, Jan. 14, 2000]
<TABLE> <S> <C>

<PAGE>
<ARTICLE>  5
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   9-MOS                   9-MOS
<FISCAL-YEAR-END>                           JAN-3-1998             DEC-28-1996
<PERIOD-START>                             DEC-29-1996             DEC-31-1995
<PERIOD-END>                                OCT-4-1997             SEP-28-1996
<CASH>                                         128,000                       0
<SECURITIES>                                         0                       0
<RECEIVABLES>                               45,764,000                       0
<ALLOWANCES>                                 1,621,000                       0
<INVENTORY>                                 70,537,000                       0
<CURRENT-ASSETS>                           118,551,000                       0
<PP&E>                                      65,553,000                       0
<DEPRECIATION>                               5,158,000                       0
<TOTAL-ASSETS>                             187,993,000                       0
<CURRENT-LIABILITIES>                       42,106,000                       0
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                       101,000                       0
<OTHER-SE>                                  81,929,000                       0
<TOTAL-LIABILITY-AND-EQUITY>               187,993,000                       0
<SALES>                                    213,347,000             262,397,000
<TOTAL-REVENUES>                           213,347,000             262,397,000
<CGS>                                      192,701,000             239,724,000
<TOTAL-COSTS>                              192,701,000             239,724,000
<OTHER-EXPENSES>                            20,041,000              22,668,000
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                          (4,884,000)            (17,929,000)
<INCOME-PRETAX>                             (4,353,000)            (19,937,000)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                         (4,353,000)            (19,937,000)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0             111,650,000
<CHANGES>                                            0                       0
<NET-INCOME>                                (4,353,000)             98,211,000
<EPS-PRIMARY>                                    (0.43)                      0
<EPS-DILUTED>                                    (0.43)                      0
        

</TABLE>
#### Manchester Memorial Hospital *v.*Norman E. Whitney et al.

*Norman E. Whitney,*pro se, on the petition.

Submitted December 11

decided December 16, 1969

The petition by the named defendant for leave to file a late notice of a petition for certification for appeal from the Appellate Division of the Circuit Court is denied.
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.5925 Powered emergency ventilator. ( a ) *Identification.* A powered emergency ventilator is a demand valve or inhalator intended to provide emergency respiratory support by means of a face mask or a tube inserted into a patient's airway.
( b ) *Classification.* Class II (performance standards).
<PAGE>   1

                                  EXHIBIT 21.1

                             Subsidiaries of Bancorp

        Columbia Bancorp's wholly-owned subsidiaries as of December 31, 1998
were Columbia River Bank, Valley Community Bank, and Valley Community Mortgage
Services, Inc.
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of Central Wireless, Inc. (the
"Company") on Form 10-QSB for the period ended September 30, 2003 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), each
of the undersigned, in the capacities and on the dates indicated below, hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to his knowledge:

      1. The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      2. The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation of the
Company.

Date: March 19, 2004                    By: /s/ Kenneth W. Brand
                                           -------------------------------------
                                           Name:  Kenneth W. Brand
                                           Title: Chief Executive Officer and
                                                  Acting Chief Executive Officer

      A signed original of this written statement required by Section 906, or
other document authentications, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Central
Wireless, Inc. and will be retained by Central Wireless, Inc. and furnished to
the Securities and Exchange Commission or its staff upon request.
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.3118 N,N′-(9,10-Dihydro-9,10-dioxo-1,5-anthracenediyl) bisbenzamide. ( a ) *Identity.* The color additive is *N*,*N*′-(9,10-dihydro-9,10-dioxo-1,5-anthracenediyl) bisbenzamide (CAS Reg. No. 82-18-8), Colour Index No. 61725.
( b ) *Uses and restrictions.* ( 1 ) The substance listed in paragraph (a) of this section may be used as a color additive in contact lenses in amounts not to exceed the minimum reasonably required to accomplish the intended coloring effect.
( 2 ) Authorization for this use shall not be construed as waiving any of the requirements of sections 510(k), 515, and 520(g) of the Federal Food, Drug, and Cosmetic Act with respect to the contact lens in which the color additive is used.
( c ) *Labeling.* The label of the color additive shall conform to the requirements of § 70.25 of this chapter.
( d ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore the color additive is exempt from the certification requirements of section 721(c) of the act.
[48 FR 31375, July 8, 1983]
#### § 58.83 Reagents and solutions.

All reagents and solutions in the laboratory areas shall be labeled to indicate identity, titer or concentration, storage requirements, and expiration date. Deteriorated or outdated reagents and solutions shall not be used.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED SEPTEMBER
30, 1988 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                          29,540
<SECURITIES>                                         0
<RECEIVABLES>                                   39,402
<ALLOWANCES>                                     3,143
<INVENTORY>                                      2,854
<CURRENT-ASSETS>                                83,389
<PP&E>                                          91,060
<DEPRECIATION>                                  33,195
<TOTAL-ASSETS>                                 480,824
<CURRENT-LIABILITIES>                           59,998
<BONDS>                                         72,173
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           299
<OTHER-SE>                                     348,354
<TOTAL-LIABILITY-AND-EQUITY>                   480,824
<SALES>                                        135,032
<TOTAL-REVENUES>                               135,032
<CGS>                                           39,080
<TOTAL-COSTS>                                   39,080
<OTHER-EXPENSES>                               122,137
<LOSS-PROVISION>                                   512
<INTEREST-EXPENSE>                               2,119
<INCOME-PRETAX>                               (28,420)
<INCOME-TAX>                                       557
<INCOME-CONTINUING>                           (29,807)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                    830
<CHANGES>                                            0
<NET-INCOME>                                  (29,807)
<EPS-PRIMARY>                                   (1.04)
<EPS-DILUTED>                                        0
        

</TABLE>
Exhibit 23.2

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in this Registration Statement of
PSEG Power LLC (the "Company"), PSEG Fossil LLC, PSEG Nuclear LLC and PSEG
Energy Resources & Trade LLC on Form S-4 of our report dated February 15, 2002,
appearing in the  Annual Report on Form 10-K of the Company for the year ended
December 31, 2001, and to the reference to us under the heading "Experts" in the
Prospectus which is part of this Registration Statement.

DELOITTE & TOUCHE LLP
Parsippany, New Jersey

August 8, 2002
Exhibit 31.2 CERTIFICATIONS I, Marcia OBrien, certify that: 1.

I
have reviewed this Form 10-Q of CNS, Inc.;  2.

Based
on my knowledge,  this report does not contain any untrue statement of a
material fact or          omit to state a material fact necessary to make the statements
made, in light of the  circumstances  under          which such  statements  were made,
 not  misleading  with respect to the period  covered by this report;  3.

Based
on my  knowledge,  the  financial  statements,  and other  financial  information
 included  in this report,  fairly present in all material respects
the financial condition,  results of operations          and cash flows of the registrant
as of, and for, the periods presented in this report;  4.

The registrants
other certifying officer(s) and I are responsible  for  establishing  and  maintaining  disclosure  controls and procedures
(as defined in          Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and
have:  a)

Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material  information  relating to
                 the  registrant,  including its  consolidated  subsidiaries,  is made
known to us by others within                  those entities, particularly during the
period in which this report is being prepared;  b)

Evaluated
the  effectiveness of the registrants  disclosure  controls and procedures and presented in
this report our conclusions about the effectiveness of the disclosure controls and procedures, as of
the end of the period covered by this report based on such evaluation; and  c)

Disclosed in this report any
change in the registrants internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrant's fourth
fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial reporting; and  5.

The registrants other certifying
officer(s) and I have  disclosed,  based on our most  recent  evaluation of internal control over
financial reporting,  to the  registrants
 auditors  and the  audit          committee of registrants board of directors (or
persons performing the equivalent function):  a)

All
 significant  deficiencies and material weaknesses in the  design or  operation  of  internal  control over
financial reporting  which are reasonably likely to adversely
 affect the  registrants  ability to record,
 process,  summarize and report  financial information; and  b)

Any
fraud,  whether or not  material,  that  involves  management  or other  employees  who
have a significant role in the registrants internal control over financial reporting.  Date: August 12, 2003
     By: /s/ Marcia OBrienMarcia OBrien Interim Chief Financial Officer
**Exhibit 32.1**

 

**CERTIFICATION PURSUANT TO**

 

**18 U.S.C. SECTION 1350,**

 

**AS ADOPTED PURSUANT TO**

 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report ofebix.com, Inc. (the “Company”) on Form 10-Q for the period that ended June 30,2003, as filed with the Securities and Exchange Commission on the date hereof(the “Report”), I, Robin Raina, Chief Executive Officer of the Company,certify, pursuant to 18 U.S.C.  1350, asadopted pursuant to  906 of theSarbanes-Oxley Act of 2002, that:

 

1.  The Report fully complies with the requirements of section 13(a) or15(d) of the Securities Exchange Act of 1934; and

 

2.  The information contained in the Report fairly presents, in allmaterial respects, the financial condition and result of operations of theCompany.

 

 
| Date:  | August 13, 2003 | By:    | /s/ Robin Raina         |   |
|--------|-----------------|--------|-------------------------|--------|
|   |            |   | Robin Raina             |
|   |            |   | Chief Executive Officer |

 

----
In The Matter Of: 

MOUNTAIN 

AIR CARGO, INC. 

Respondent 

SERVED: OCTOBER 17,2014 

U.S. DEPARTMENT OF TRANSPORTATION 

OFFICE OF HEARINGS 

W ASIDNGTON, DC 

) 

) 

) 

) 

) 

) 

Docket No. FAA-2014-0111 

Case No. 2013EA680043 

ORDER DISMISSING PROCEEDING 

On October 7, 2014, an Order Granting FAA Motion for Second Extension ofTime to 

File a Reply was filed. This Order noted that the parties had reached a settlement agreement in 

principle, but needed time to agree to the exact details. 

On October 14, 2014, the Respondent filed a one-page letter, requesting withdrawal of its 

request for a formal hearing on the grounds that the parties had settled the case. 

After having reviewed the case file, all pleadings and motions, all relevant caselaw, 

statutes, regulations, rules, and authority, and being fully advised; 

IT IS HEREBY ORDERED: 

1. The FAA's pending Motion for Decision is deemed moot. 

2. The Hearing set for March 24-25, 2015, in Charlotte, North Carolina is cancelled. 

3. Pursuant to 14 C.F.R. § 13.215, the Respondent has withdrawn its Request for Hearing, 

and this proceeding is dismissed with prejudice. 

Attachment: Service List 
SERVICE LIST- BY U.S. MAIL 

Federal Aviation Administration 

800 Independence A venue, S. W. 

Washington, DC 20591 

ORIGINAL & ONE COPY 

Attention: Hearing Docket Clerk, AGC-430 

Wilbur Wright Building-Suite 2W1 0001 

Mr. Zachary M. Berman 

Complainant's Counsel 

Office of the Chief Counsel 

Federal Aviation Administration 

1 Aviation Plaza 

Jamaica, NY 11434 

TEL: 718-553-3258 

FAX: 718-995-5699 

Mr. Mark A. Dombroff 

Respondent's Counsel 

McKenna Long & Aldridge 

1676 International Drive PH 

McLean, VA 22102 

TEL: 703-336-8700 

FAX: 703-336-8750 

Judge J.E. Sullivan 

U.S. Administrative Law Judge 

Office ofHearings, M-20 

U.S. Department of Transportation 

ONE COPY 

1200 New Jersey Avenue, S.E. (E11-310) 

Washington, DC 20590 

TEL: 202-366-6941 

FAX: 202-366-7536 

Docket No. FAA-2014-0111 

(Civil Penalty Action) 

1 Service was by U.S. Mail. For service in person or by expedited courier, use the following address: Federal 

Aviation Administration, 600 Independence Avenue, S.W., Wilbur Wright Building-Suite 2Wl000, Washington, 

DC 20591; Attention: Hearing Docket Clerk, AGC-430.
# C_2019025EN.01003702.xml

| 21.1.2019 | EN | Official Journal of the European Union | C 25/37 |
| --- | --- | --- | --- |

21.1.2019

EN

Official Journal of the European Union

C 25/37

---

Judgment of the General Court of 15 November 2018 — CHEMK and KF v Commission

(Case T-487/14) (1)

((Dumping - Imports of ferro-silicon originating in Russia - Definitive anti-dumping duty - Expiry review - Determination of the export price - Single economic entity - Reflection of the anti-dumping duty in resale prices in the European Union - Application of a methodology different from that used in an earlier investigation - Continuation or recurrence of dumping and injury - Article 2(9), Article 3 and Article 11(9) and (10) of Regulation (EC) No 1225/2009 (now Article 2(9), Article 3 and Article 11(9) and (10) of Regulation (EU) 2016/1036)))

(2019/C 25/47)

Language of the case: English

Parties

Applicants: Chelyabinsk electrometallurgical integrated plant OAO (CHEMK) (Chelyabinsk, Russia) and Kuzneckie Ferrosplavy OAO (KF) (Novokuznetsk, Russia) (represented by: B. Evtimov and M. Krestiyanova, lawyers)

Defendant: European Commission (represented by: M. França, J.-F. Brakeland, A. Stobiecka-Kuik and A. Demeneix, Agents)

Intervener in support of the defendant: Euroalliages (Brussels, Belgium) (represented by: O. Prost and M.-S. Dibling, lawyers)

Re:

Application under Article 263 TFEU for annulment of Commission Implementing Regulation (EU) No 360/2014 of 9 April 2014 imposing a definitive anti-dumping duty on imports of ferro-silicon originating in the People’s Republic of China and Russia, following an expiry review pursuant to Article 11(2) of Council Regulation (EC) No 1225/2009 (OJ 2014 L 107, p. 13), in so far as it concerns the applicants.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Chelyabinsk electrometallurgical integrated plant OAO (CHEMK) and Kuzneckie Ferrosplavy OAO (KF) to bear their own costs and to pay those incurred by the European Commission; |
| --- | --- |

2.

Orders Chelyabinsk electrometallurgical integrated plant OAO (CHEMK) and Kuzneckie Ferrosplavy OAO (KF) to bear their own costs and to pay those incurred by the European Commission;

| 3. | Orders Euroalliages to bear its own costs. |
| --- | --- |

3.

Orders Euroalliages to bear its own costs.

---

(1)  OJ C 282, 25.8.2014.

---
#### Colchester Egg Farms, Inc. *v.*Chernoff-Lockwood Insurance Agency, Inc.

It appearing that the plaintiff in the above-entitled case has failed to prosecute its appeal from the Superior Court in Hartford County with proper diligence, it is, under Practice Book § 696, ordered by the Supreme Court, suo motu, that the appeal be and hereby is dismissed.

*662
      *Daniel J. Hagearty, Jr.,*for the appellant (plaintiff).

*Thomas F. Parker,*for the appellee (defendant).

Argued December 2

decided December 2, 1969